可切除壶腹周围癌的早期肝转移:发生率与危险因素
本研究回顾性纳入2003年1月至2016年6月因壶腹周围癌(除外十二指肠癌)行胰十二指肠切除术且有术前术后CT的132例患者,27例(20.5%)发生肝转移,平均诊断时间103.9±55.2天,81.4%为多发、59.3%为双叶,平均最大径16.7±12.7mm;单因素分析脉管癌栓与肝转移显著相关(p=0.02),多因素分析未发现独立危险因素;早期复发独立危险因素为术前CT肿瘤>23mm(OR 3.3)和肿瘤分化程度(差 vs 好 OR 15.5;中 vs 好 OR 17.1)。
要点
- 壶腹周围癌胰十二指肠切除术后6个月内肝转移发生率20.5%(27/132),平均诊断时间103.9±55.2天。
- 肝转移多为多发(81.4%)和双叶分布(59.3%),平均最大径16.7±12.7mm。
- 术前CT肿瘤>23mm及肿瘤分化差/中是早期复发的独立危险因素,脉管癌栓仅单因素相关。
核心结论
- 近五分之一的壶腹周围癌患者胰十二指肠切除术后6个月内发生肝转移且模式高度一致;作者认为术前3周内联合CT与MRI充分评估、术后8周常规系统CT扫描(辅助化疗前)似乎是必要的;手术方式似乎不是危险因素,肝转移风险似乎与肿瘤脉管侵犯及可能的分化程度有关,这些因素影像无法评估。
研究设计与样本
- 回顾性研究,纳入2003年1月至2016年6月在本机构因壶腹周围癌(除外十二指肠癌)行胰十二指肠切除术且有 adequate 术前和术后CT扫描的患者132例;采用单因素和多因素logistic回归分析与早期肝转移及复发相关的因素。
关键影像表现/征象
- 肝转移在81.4%的病例中为多发,在59.3%的病例中为双叶分布。
- 肝转移的平均最大径为16.7±12.7mm。
- 肝转移的平均诊断时间为103.9±55.2天。
诊断标准与关键数值
- 早期肝转移定义为术后6个月内发生的肝转移(<6个月)。
- 单因素logistic分析显示脉管癌栓与肝转移显著相关(p=0.02)。
- 多因素logistic分析未发现肝转移的独立危险因素。
- 早期复发的独立危险因素:术前CT肿瘤大小>23mm(OR 3.3;95% CI [1.2-9.3];p=0.02);肿瘤分化程度差 vs 好(OR 15.5;95% CI [1.5-158.3])、中 vs 好(OR 17.1;95% CI [1.9-154.4]),p=0.04。
临床应用与阅片要点
- 作者认为术前3周内联合CT与MRI充分评估似乎是必要的。
- 作者认为在开始辅助化疗前,术后8周常规系统CT扫描也是必要的。
- 作者认为手术方式似乎不是肝转移的危险因素,肝转移风险似乎与肿瘤脉管侵犯及可能的分化程度相关,而这些因素影像无法评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The aim of the present study was to estimate the incidence of very early hepatic metastases (HMs) (<6 months) and their imaging patterns after cephalic duodenopancreatectomy (CDP) for periampullary carcinoma (excluding duodenal carcinoma) and to identify their associated risk factors.
METHODS: From January 2003 to June 2016, all patients who underwent surgical treatment for periampullary carcinoma by CDP at our institution and with adequate pre- and postoperative CT scans were included. Univariate and multivariate logistic regressions were performed to determine factors associated with very early HM and recurrence.
RESULTS: Of the 132 patients included retrospectively, 27 (20.5%) patients developed HMs. The mean time to diagnosis of HM was 103.9±55.2days. HMs were multiple in 81.4% of cases and bilobar in 59.3% of cases; their mean maximum size was 16.7±12.7mm. In univariate logistic analysis, lymphovascular emboli were significantly associated with HM (p=0.02). No independent risk factors for HM were found in multivariate analysis. In multivariate logistic analysis, two independent risk factors were identified for the occurrence of early recurrence: tumor size >23mm on preoperative CT scan (OR: 3.3; 95% CI: [1.2-9.3]; p=0.02) and tumor differentiation (poor vs. good: OR 15.5; 95 CI [1.5-158.3]; moderate vs. good: OR: 17.1; 95% CI: [1.9-154.4]; p=0.04).
CONCLUSIONS: Nearly one in five patients developed HM after CDP within 6 months with a highly consistent pattern. A thorough preoperative assessment, combining CT scan and MRI with a delay of less than three weeks before surgery, appears essential. A routine systematic postoperative CT scan at 8 weeks is also required prior to initiating adjuvant chemotherapy. The type of surgical intervention does not seem to be a risk factor, although the risk of HM occurrence appears to be related to the lymphovascular invasion of the tumor and maybe its degree of differentiation, elements not assessable by imaging.
引用
- Guerard AS, Ayav A, Busby H, et al. Early liver metastases in resectable periampullary cancer: Incidence and risk factors. Eur J Radiol. 2017. PMID: 28668425. doi:10.1016/j.ejrad.2017.06.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。